Automatic Detection of Eligible Patients to RAUC Protocol (RAUCISABLE)
NCT ID: NCT07037719
Last Updated: 2025-06-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
300000 participants
OBSERVATIONAL
2025-01-17
2026-01-17
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of the InterFACE-AR System for Cardiopulmonary Arrest
NCT06411327
Closed-Loop Titration of Vasopressor Infusions: Feasibility Study or Proof of Concept Study
NCT03515161
AmbulaNCE Teletransmited PHOtography for Trauma REgulation
NCT04034797
REmote Data Acquisition After SURgery
NCT04480385
Out of Hospital Cardiac Arrest: Trial Assessing the Survival Impact of Phone Advice
NCT02934867
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients attending CHU Amiens-Picardie Emergency Department
Adults (age 17+), all ED patients
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire, Amiens
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jean-Marc REGIMBEAU, MD
Role: PRINCIPAL_INVESTIGATOR
CHU Amiens-Picardie
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU Amiens-Picardie
Amiens, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PI2025_843_0015
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.